A non-comparative, open, Phase II study of ruxolitinib in polycythemia vera subjects who are resistant to or intolerant of hydroxyurea or Interferon alpha
| Title | A non-comparative, open, Phase II study of ruxolitinib in polycythemia vera subjects who are resistant to or intolerant of hydroxyurea or Interferon alpha |
|---|---|
| Description | The emerging efficacy and safety profile for ruxolitinib supports further studies in Chinese PV subjects who demonstrate resistance or intolerance to HU or IFN-α therapy. The purpose of this trial is to demonstrate clinically meaningful responses in PV subjects receiving ruxolitinib |
| Organism | Homo sapiens |
| Data Type | Other Type of Genomic Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA022414 |
| Release Date | 2023-12-29 |
| Submitter | yating liu (liuyating@ihcams.ac.cn) |
| Organization | Institute of hematology&Blood diseases hospital, Chinese academy of medical sciences&Peking union medical college |
| Submission Date | 2023-12-27 |
The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX005494-01 | ruxolitinib in polycythemia vera subjects who are resistant to or intolerant of hydroxyurea or Interferon alpha | 34 | Other Type of Genomic Data | 157.2 KB | xlsx | 0 | Unavailable |